Clinical Trials
71 trialsMEN-301
NX Development Corp
A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma
Heron Neutron Medical Corp.
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
CBT-I in PBT
Virginia Commonwealth University
Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
National Institutes of Health Clinical Center (CC)
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Cedars-Sinai Medical Center
STAMP
Beijing Tiantan Hospital
Proton Radiation For Meningiomas and Hemangiopericytomas
Abramson Cancer Center at Penn Medicine
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
St. Jude Children's Research Hospital
Closed vs. Open Face Masks for Cranial Radiotherapy
University of Zurich
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
National Cancer Institute (NCI)
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
National Institutes of Health Clinical Center (CC)
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Radiation Therapy Oncology Group
Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas
M.D. Anderson Cancer Center
CEVOREM
Assistance Publique Hopitaux De Marseille
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
University of Iowa
AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Massachusetts General Hospital
LSCI-NSURG
Insel Gruppe AG, University Hospital Bern
Safety Study of Afatinib for Brain Cancer
Saint John's Cancer Institute
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Wake Forest University Health Sciences
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Wake Forest University Health Sciences
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
Wake Forest University Health Sciences
SCUSF1202
University of South Florida
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
National Institutes of Health Clinical Center (CC)
Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
UNICANCER
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Northwestern University
Magnesium and Intraoperative Blood Loss in Meningioma Surgery
Mahidol University
Stereotactic Body Radiotherapy for Spine Tumors
Mercy Research
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
NYU Langone Health
Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATEâ„¢
Clarity Pharmaceuticals Ltd
Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery Quality
RenJi Hospital
S9005 Mifepristone in Meningioma
SWOG Cancer Research Network
Dexanabinol in Patients With Brain Cancer
University of California, San Diego
FGR
Dartmouth-Hitchcock Medical Center
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Medical College of Wisconsin
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
Northwestern University
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
Wake Forest University Health Sciences
SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors
City of Hope Medical Center
Monthly SOM230C for Recurrent or Progressive Meningioma
Dana-Farber Cancer Institute
Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
National Cancer Institute (NCI)
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
NYU Langone Health
Proton/Photon Rt - Benign Meningiomas(P92-13)
Massachusetts General Hospital
Imatinib Mesylate in Treating Patients With Recurrent Meningioma
National Cancer Institute (NCI)
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
University of Utah
Information Presentation Formats
Carnegie Mellon University
alloCTL
Jonsson Comprehensive Cancer Center